These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20979574)

  • 21. Porphyria cutanea tarda associated with Cys282Tyr mutation in HFE gene in hereditary hemochromatosis: a case report and review of the literature.
    Young LC
    Cutis; 2007 Nov; 80(5):415-8. PubMed ID: 18189029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic hemochromatosis, a Celtic disease: is it now time for population screening?
    Byrnes V; Ryan E; Barrett S; Kenny P; Mayne P; Crowe J
    Genet Test; 2001; 5(2):127-30. PubMed ID: 11551098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The S65C mutation in Spain. Implications for iron overload screening.
    Remacha AF; Barceló MJ; Sardà MP; Blesa I; Altés A; Baiget M
    Haematologica; 2000 Dec; 85(12):1324-5. PubMed ID: 11114141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA testing for haemochromatosis: diagnostic, predictive and screening implications.
    Trent RJ; Le H; Yu B; Young G; Bowden DK
    Pathology; 2000 Nov; 32(4):274-9. PubMed ID: 11186424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic iron metabolism gene expression profiles in HFE associated hereditary hemochromatosis.
    Gleeson F; Ryan E; Barrett S; Russell J; Crowe J
    Blood Cells Mol Dis; 2007; 38(1):37-44. PubMed ID: 17098454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hereditary hemochromatosis: HFE mutation analysis in Greeks reveals genetic heterogeneity.
    Papanikolaou G; Politou M; Terpos E; Fourlemadis S; Sakellaropoulos N; Loukopoulos D
    Blood Cells Mol Dis; 2000 Apr; 26(2):163-8. PubMed ID: 11001626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychosocial aspects of DNA testing for hereditary hemochromatosis in at-risk individuals: a systematic review.
    Picot J; Bryant J; Cooper K; Clegg A; Roderick P; Rosenberg W; Patch C
    Genet Test Mol Biomarkers; 2009 Feb; 13(1):7-14. PubMed ID: 19309267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening for C282Y homozygosity in a Norwegian population (HUNT2): The sensitivity and specificity of transferrin saturation.
    Thorstensen K; Kvitland MA; Irgens WØ; Hveem K; Asberg A
    Scand J Clin Lab Invest; 2010 Apr; 70(2):92-7. PubMed ID: 20073670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of C282Y, H63D and S65C mutations of the hemochromatosis (HFE) gene in a population from southeastern Spain (Murcia Region).
    Muro M; Moya-Quiles MR; Botella C; Alvarez-López MR
    Clin Genet; 2007 Jan; 71(1):97-8. PubMed ID: 17204056
    [No Abstract]   [Full Text] [Related]  

  • 30. HFE gene mutations in patients with primary iron overload: is there a significant improvement in molecular diagnosis yield with HFE sequencing?
    Santos PC; Pereira AC; Cançado RD; Schettert IT; Sobreira TJ; Oliveira PS; Hirata RD; Hirata MH; Figueiredo MS; Chiattone CS; Krieger JE; Guerra-Shinohara EM
    Blood Cells Mol Dis; 2010 Dec; 45(4):302-7. PubMed ID: 20843714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hereditary hemochromatosis should be considered a conformational disorder.
    Lawless MW; Mankan AK; Norris S
    Med Hypotheses; 2008; 70(4):783-4. PubMed ID: 17904763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Case report of HFE gene testing for the diagnosis of hereditary hemochromatosis.
    Pan HY; Wang LJ
    J Dig Dis; 2011 Oct; 12(5):409-11. PubMed ID: 21955435
    [No Abstract]   [Full Text] [Related]  

  • 33. Severity of iron overload of proband determines serum ferritin levels in families with HFE-related hemochromatosis: the HEmochromatosis FAmily Study.
    Jacobs EM; Hendriks JC; van Deursen CT; Kreeftenberg HG; de Vries RA; Marx JJ; Stalenhoef AF; Verbeek AL; Swinkels DW
    J Hepatol; 2009 Jan; 50(1):174-83. PubMed ID: 19008010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of HFE (hemochromatosis) mutations as genetic modifiers in sporadic AD and MCI.
    Berlin D; Chong G; Chertkow H; Bergman H; Phillips NA; Schipper HM
    Neurobiol Aging; 2004 Apr; 25(4):465-74. PubMed ID: 15013567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenesis of hereditary hemochromatosis: genetics and beyond.
    Britton RS; Fleming RE; Parkkila S; Waheed A; Sly WS; Bacon BR
    Semin Gastrointest Dis; 2002 Apr; 13(2):68-79. PubMed ID: 12064862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EASL clinical practice guidelines for HFE hemochromatosis.
    European Association For The Study Of The Liver
    J Hepatol; 2010 Jul; 53(1):3-22. PubMed ID: 20471131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hereditary hemochromatosis.
    Fix OK; Kowdley KV
    Minerva Med; 2008 Dec; 99(6):605-17. PubMed ID: 19034258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural history and management of HFE-hemochromatosis.
    Gan EK; Powell LW; Olynyk JK
    Semin Liver Dis; 2011 Aug; 31(3):293-301. PubMed ID: 21901659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hereditary hemochromatosis: the clinical significance of the S65C mutation.
    Asberg A; Thorstensen K; Hveem K; Bjerve KS
    Genet Test; 2002; 6(1):59-62. PubMed ID: 12180078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective role of calreticulin in HFE hemochromatosis.
    Pinto JP; Ramos P; de Almeida SF; Oliveira S; Breda L; Michalak M; Porto G; Rivella S; de Sousa M
    Free Radic Biol Med; 2008 Jan; 44(1):99-108. PubMed ID: 18045552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.